62 related articles for article (PubMed ID: 18502115)
1. Fructose 1,6-Bisphosphatase 1 Expression Reduces
Chen R; Zhou X; Huang G; Liu J
Contrast Media Mol Imaging; 2019; 2019():9463926. PubMed ID: 30723389
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive nephrectomy in the modern era: Predictors of use, morbidity, and survival.
Minnillo BJ; Tabayoyong W; Francis JJ; Maurice MJ; Zhu H; Kim S; Abouassaly R
Can Urol Assoc J; 2017 May; 11(5):E184-E191. PubMed ID: 28503232
[TBL] [Abstract][Full Text] [Related]
3. Better survival of renal cell carcinoma in patients with inflammatory bowel disease.
Derikx LA; Nissen LH; Drenth JP; van Herpen CM; Kievit W; Verhoeven RH; Mulders PF; Hulsbergen-van de Kaa CA; Boers-Sonderen MJ; van den Heuvel TR; Pierik M; Nagtegaal ID; Hoentjen F; ; ;
Oncotarget; 2015 Nov; 6(35):38336-47. PubMed ID: 26447542
[TBL] [Abstract][Full Text] [Related]
4. Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients.
Teixeira AL; Ferreira M; Silva J; Gomes M; Dias F; Santos JI; Maurício J; Lobo F; Medeiros R
Tumour Biol; 2014 May; 35(5):4057-66. PubMed ID: 24379138
[TBL] [Abstract][Full Text] [Related]
5. A GWAS-identified susceptibility locus on chromosome 11q13.3 and its putative molecular target for prediction of postoperative prognosis of human renal cell carcinoma.
Su T; Han Y; Yu Y; Tan X; Li X; Hou J; DU Y; Shen J; Wang G; Ma L; Jiang S; Zhang H; Cao G
Oncol Lett; 2013 Aug; 6(2):421-426. PubMed ID: 24137339
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma.
Yamada Y; Hidaka H; Seki N; Yoshino H; Yamasaki T; Itesako T; Nakagawa M; Enokida H
Cancer Sci; 2013 Mar; 104(3):304-12. PubMed ID: 23176581
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.
Hidaka H; Seki N; Yoshino H; Yamasaki T; Yamada Y; Nohata N; Fuse M; Nakagawa M; Enokida H
Oncotarget; 2012 Jan; 3(1):44-57. PubMed ID: 22294552
[TBL] [Abstract][Full Text] [Related]
8. Are all multi-targeted tyrosine kinase inhibitors created equal? An in vitro study of sunitinib and pazopanib in renal cell carcinoma cell lines.
Canter D; Kutikov A; Golovine K; Makhov P; Simhan J; Uzzo RG; Kolenko VM
Can J Urol; 2011 Aug; 18(4):5819-25. PubMed ID: 21854714
[TBL] [Abstract][Full Text] [Related]
9. Accurate molecular classification of renal tumors using microRNA expression.
Fridman E; Dotan Z; Barshack I; David MB; Dov A; Tabak S; Zion O; Benjamin S; Benjamin H; Kuker H; Avivi C; Rosenblatt K; Polak-Charcon S; Ramon J; Rosenfeld N; Spector Y
J Mol Diagn; 2010 Sep; 12(5):687-96. PubMed ID: 20595629
[TBL] [Abstract][Full Text] [Related]
10. New treatments for metastatic kidney cancer.
Mancuso A; Sternberg CN
Can J Urol; 2005 Feb; 12 Suppl 1():66-70; discussion 105. PubMed ID: 15780170
[TBL] [Abstract][Full Text] [Related]
11. Vaccine therapy in patients with renal cell carcinoma.
Van Poppel H; Joniau S; Van Gool SW
Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
[TBL] [Abstract][Full Text] [Related]
12. No improvement in renal cell carcinoma survival: a population-based study in the Netherlands.
Aben KK; Luth TK; Janssen-Heijnen ML; Mulders PF; Kiemeney LA; van Spronsen DJ
Eur J Cancer; 2008 Aug; 44(12):1701-9. PubMed ID: 18502115
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
[TBL] [Abstract][Full Text] [Related]
14. Metastatic renal cell carcinoma: results of a population-based study with 25 years follow-up.
Schlesinger-Raab A; Treiber U; Zaak D; Hölzel D; Engel J
Eur J Cancer; 2008 Nov; 44(16):2485-95. PubMed ID: 18783939
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary resections for metastatic renal cell carcinoma in Iceland].
Oddsson SJ; Isaksson HJ; Jonsson E; Einarsson GV; Gudbjartsson T
Laeknabladid; 2008 May; 94(5):377-81. PubMed ID: 18460734
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
